Literature DB >> 7772082

Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding.

J H van Ree1, M J Gijbels, W J van den Broek, M H Hofker, L M Havekes.   

Abstract

Apolipoprotein (apo) E-deficient mice were fed a hypercholesterolemic diet for 14 weeks. Mean serum cholesterol levels rose to 37.5 mM. Upon complete necroscopy, massive xanthomatous lesions were noticed in various tissues, with a predilection for subcutaneous and peritendinous tissues, while control animals on the same diet (3.4 mM serum cholesterol) and apo E-deficient mice on a regular chow diet (20 mM serum cholesterol) did not show such lesions. Also, apo E3-Leiden transgenic mice fed a high fat diet, with 60 mM of serum cholesterol, did not exhibit any xanthomatosis. The xanthomatous lesions found in the Apoe knock-out mouse clearly differed in location from xanthomas previously found in low density lipoprotein receptor-deficient mice. We conclude that the lack of apo E results in atypical disseminated xanthomatosis, suggesting that apo E has an important role in determining the tissue distribution of cholesterol deposition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7772082     DOI: 10.1016/0021-9150(94)05419-j

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

1.  Severe xanthomatosis associated with familial apolipoprotein E deficiency.

Authors:  G Feussner
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

2.  Cerebral lipid deposition in aged apolipoprotein-E-deficient mice.

Authors:  L C Walker; C A Parker; W J Lipinski; M J Callahan; R T Carroll; S E Gandy; J D Smith; M Jucker; C L Bisgaier
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

3.  Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.

Authors:  M Accad; S J Smith; D L Newland; D A Sanan; L E King; M F Linton; S Fazio; R V Farese
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

4.  A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia.

Authors:  G Feussner; J Dobmeyer; H J Gröne; S Lohmer; S Wohlfeil
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

5.  Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration.

Authors:  Hwee Ying Lim; Joseph M Rutkowski; Julie Helft; Sai T Reddy; Melody A Swartz; Gwendalyn J Randolph; Véronique Angeli
Journal:  Am J Pathol       Date:  2009-08-13       Impact factor: 4.307

6.  Accumulation of oxidized LDL in the tendon tissues of C57BL/6 or apolipoprotein E knock-out mice that consume a high fat diet: potential impact on tendon health.

Authors:  Navdeep Grewal; Gail M Thornton; Hayedeh Behzad; Aishwariya Sharma; Alex Lu; Peng Zhang; W Darlene Reid; David J Granville Alex Scott
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

7.  Halted Lymphocyte Egress via Efferent Lymph Contributes to Lymph Node Hypertrophy During Hypercholesterolemia.

Authors:  Meng Hwee Daniel Tay; Swee Yeng Jason Lim; Yew Fai Ivan Leong; Chung Hwee Thiam; Kar Wai Tan; Federico Tesio Torta; Pradeep Narayanaswamy; Markus Wenk; Véronique Angeli
Journal:  Front Immunol       Date:  2019-03-27       Impact factor: 7.561

Review 8.  The role of the lymphatic system in cholesterol transport.

Authors:  Li-Hao Huang; Andrew Elvington; Gwendalyn J Randolph
Journal:  Front Pharmacol       Date:  2015-09-02       Impact factor: 5.810

9.  The thyroid receptor modulator KB3495 reduces atherosclerosis independently of total cholesterol in the circulation in ApoE deficient mice.

Authors:  Lisa-Mari Mörk; Stefan Rehnmark; Padideh Davoodpour; Giuseppe Danilo Norata; Lilian Larsson; Michael-Robin Witt; Johan Malm; Paolo Parini
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

10.  Familial dysbetalipoproteinaemia presenting with cauliflower xanthoma.

Authors:  Akbar Aliasgarzadeh; Maryam Ghorbanian; Mohammad Naghavi-Behzad
Journal:  Niger Med J       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.